Skip to main content
Voronoi, Inc. logo

Voronoi, Inc. — Investor Relations & Filings

Ticker · 310210 ISIN · KR7310210000 KO Manufacturing
Open in API
Filings indexed 238 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 310210

About Voronoi, Inc.

https://voronoi.io

Voronoi, Inc. is a biotechnology company that specializes in the research and development of novel therapeutics for challenging diseases. The company's core expertise lies in creating innovative small molecule kinase inhibitors and target protein degrader drugs. Utilizing its proprietary AI-powered drug discovery platform, VORONOMICS, Voronoi accelerates the identification and optimization of promising drug candidates. This platform enables the rapid design of therapies with high selectivity and brain penetration, primarily targeting various forms of cancer and other difficult-to-treat conditions.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 98% confidence The document is titled “분기보고서” covering the period January 1, 2026 to March 31, 2026 and filed on May 15, 2026 with the Financial Services Commission and KRX. It contains detailed financial statements (연결재무제표, 재무제표 및 주석), management’s discussion and analysis, audit opinion, board and shareholder information, and other comprehensive disclosures. This matches the definition of an Interim/Quarterly Report. Q1 2026
2026-05-15 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 78% confidence The document is a Korean-language announcement scheduling an investor relations corporate presentation meeting (IR) including date, time, location, participants, agenda items, and contact details. It does not contain substantive financial statements or serve as the actual presentation, but is a regulatory notice of an upcoming IR event. There is no fitting specific category for IR event notices, so it falls under the general Regulatory Filings (RNS) fallback category.
2026-05-13 Korean
주요사항보고서(전환사채매수선택권행사자지정)
Regulatory Filings
2026-05-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 90% confidence The document is a Korean insider ownership report titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” detailing an officer’s shareholding changes, including specific securities, quantities, dates, and transaction reasons (gifts to spouse). This matches the definition of a Director’s Dealing report (insider share transactions by company directors).
2026-04-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a Korean regulatory filing titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” detailing an executive’s (임원) share ownership changes, including acquisition/disposition of shares. This matches the definition of an insider reporting personal share transactions by company directors/executives. Hence, it is a Director’s Dealing report, code DIRS.
2026-04-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is a “주식등의 대량보유상황보고서(일반)” – a large shareholding report filed under Korean capital markets law, detailing the number of shares held by a major shareholder and related parties, changes in holdings, purpose, and contracts. This corresponds to a Major Shareholding Notification, not a financial report, earnings release, or AGM material. Therefore, the appropriate classification is MRQ.
2026-04-15 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.